Al Gore returned to Congress today to testify about global warming. He even spoke before the committee chaired by Rep. John Dingell, who hasn't exactly enlisted in the climate-change fight. John Dimsdale covered the hearings.
Investors at more than 50 companies now say they want a voice in how much the CEO makes. But commentator Robert Reich thinks shareholders are irrelevant to the real issue.
Virgin America may finally get its wings. The U.S. government has reversed its position that allowing popular overseas carrier Virgin Atlantic to operate here would violate foreign ownership rules.
Jim Gilchrist was ousted by his own company's board for allegedly using a large portion of the Minuteman's funds to promote his own book. Today a California judge will decide who gets to lead the organization.
As the subprime housing sector continues to crumble, commentator David Frum says maybe our idea of the great American dream is a little off and some people just shouldn't be buying homes.
An estimated 70% of Papua New Guinea's population lives in poverty. Men have mostly been the wage earners. But economic opportunities for women are changing traditional gender roles. Skye Rhode reports.
Democrats may have given everyone the impression they would change the pay-to-play practices on Capitol Hill. But commentator Jeff Birnbaum says it's the same story as before — maybe worse.
Your Social Security earnings statement can be a nostalgic journey back to simpler times and summer jobs… or just plain depressing. Commentator Russell Frank suggests most of us use it as a friendly reminder that money isn't everything.
The more we spend on scientific research, the greater the advances we make. Seems simple enough, but funding hasn't gone up since 2003 — so a group of U.S. scientists gave Capitol Hill a healthy reminder yesterday.
Merck's state-lobbying campaign to make their cervical cancer vaccination mandatory in schools has faced strong resistance. Backlash comes despite the fact that Gardasil has been proven very effective against the disease. Pat Loeb reports.
